1 |
Tan K, Jäger C, Geissler S, Schlenzig D, Buchholz M, Ramsbeck D. Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β. J Enzyme Inhib Med Chem 2023;38:2165648. [PMID: 36661029 DOI: 10.1080/14756366.2023.2165648] [Reference Citation Analysis]
|
2 |
Bayly-Jones C, Lupton CJ, Fritz C, Venugopal H, Ramsbeck D, Wermann M, Jäger C, de Marco A, Schilling S, Schlenzig D, Whisstock JC. Helical ultrastructure of the metalloprotease meprin α in complex with a small molecule inhibitor. Nat Commun 2022;13:6178. [PMID: 36261433 DOI: 10.1038/s41467-022-33893-7] [Reference Citation Analysis]
|
3 |
Scharfenberg F, Becker-pauly C. Protein Synthesis/Degradation: Protein Degradation – Protease Classes – Metalloproteases Meprin α and Meprin β in Health and Disease. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00050-x] [Reference Citation Analysis]
|
4 |
Werny L, Colmorgen C, Becker-Pauly C. Regulation of meprin metalloproteases in mucosal homeostasis. Biochim Biophys Acta Mol Cell Res 2022;1869:119158. [PMID: 34626680 DOI: 10.1016/j.bbamcr.2021.119158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Wang C, Diez J, Park H, Spicer TP, Scampavia LD, Becker-Pauly C, Fields GB, Minond D, Bannister TD. Discovery and Optimization of Selective Inhibitors of Meprin α (Part II). Pharmaceuticals (Basel) 2021;14:197. [PMID: 33673639 DOI: 10.3390/ph14030197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|